-
-
-
Nordic Precision Medicine Forum 2024
Stockholm Stockholm, Sweden -
Swiss Biotech Day 2024
Basel Basel, Switzerland -
DNA-seq analyses (whole genome, whole exome, panel) using QIAGEN CLC Genomics Workbench
Virtual - Americas - EST , United StatesIn this training, we’ll go over how to easily perform DNA-seq analyses (for whole genome, whole exome, panel and similar) easily and effectively using QIAGEN CLC Genomics Workbench. Together, we’ll […]
-
IPA deep dive: miRNA investigation using QIAGEN Ingenuity Pathway Analysis (IPA)
Virtual - Americas - EST , United StatesIn this 90-minute training session, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways, diseases, biological functions, tissues and cell types. We’ll cover topics such as: • How to analyze miRNA-seq datasets alone or both miRNA and corresponding mRNA datasets together • How to use QIAGEN […]
-
-
FeaturedNetwork construction and customization with QIAGEN Ingenuity Pathway Analysis
Virtual - Americas - EST , United StatesPer attendees’ requests from a recent training, we are hosting this in-depth training focused on effectively constructing a network, with or without a dataset (RNA-seq, proteomics, etc.), and easily modifying it – all within Ingenuity Pathway Analysis. In this interactive training, attendees will learn how to: • Construct a network from scratch or open a […]
-
New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)
Virtual - Americas - EST , United StatesJoin us for a 120-minute training session for new users of QIAGEN IPA. In this training, you’ll learn how to: • Upload your dataset (RNA-seq, scRNA-seq, proteomics, metabolomics and more) and perform interactive core/pathway analysis in IPA • Understand the different result types produced (pathways, key regulators, impact on biological functions/diseases and more) • Compare […]
-
International Symposium of Variants 2024
Porto Porto, Portugal -
QIAGEN Biomedical Knowledge Base: data- and analytics-driven drug discovery
Virtual - Americas - EST , United StatesIngenuity pathway analysis (IPA) which is currently cited in tens of thousands of publications and used by large number of biopharmaceuticals is backed by QIAGEN Biomedical Knowledgebase. Accordingly, Biomedical relationships knowledge has more or less become a requirement for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target […]
-
Mitigating Variability in Somatic Variant Interpretation with Live Q&A
Virtual - Americas - EST , United StatesNext-generation sequencing (NGS) oncology panels are becoming integral in hospital and academic settings to guide patient treatment and enrollment in clinical trials. But as NGS is increasingly used in precision oncology and an unprecedented amount of genomic information is uncovered, there is an industry-wide issue of standardization: a high degree of variability in variant interpretation […]
-
Leveraging the power of API-based omics (RNA-seq, proteomics and more) queries for discovery
Virtual - Americas - EST , United StatesThere is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This webinar, aimed at data scientists, bioinformaticians and similar roles in biopharma and academia, explores a comprehensive way of accessing and analyzing high-quality, expertly curated omics […]
-
FeaturedClinician’s Roundtable: Interpreting genomic test results for precision oncology
Virtual Global Event (Times shown in EST)You’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for cancer patients. As the role of the Molecular Tumor Board (MTB) becomes increasingly important in the implementation of evidence-based precision cancer medicine programs, molecular pathology […]





























